Blog
Building CGT’s Clinical Trial Potential: PRA’s Partnership with Cell and Gene Therapy Supply Chain Software Leader Vineti
Key Highlights: PRA’s partnership with Vineti will optimize clinical trial delivery, clinical study operations and data management, and commercialization readiness…
Announcing our new enterprise-grade Alliance Network — and a collaboration with Mavens — to further industrialize cell and gene therapies
Today, I’m really excited to share more progress from Vineti. We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach...
Team Vineti stands in solidarity with the Black community: Black Lives Matter
Our company was founded in 2016 to bring life to the following vision: “Vineti works to create a world where individualized,...
Amy DuRoss selected for San Francisco Business Times’ Most Influential Women of 2020
Today, we’re proud to congratulate our CEO and Co-founder, Amy DuRoss, for her selection to the prestigious San Francisco Business Times’...
Cell and gene therapy — a dose of good news
Cancer, serious genetic disorders, and other pressing health conditions never stop. Neither does cell and gene therapy. And that’s great...
Cardinal Health and Vineti announce collaboration to deliver integrated commercial and logistics solutions to cell and gene therapy manufacturers
DUBLIN, OHIO and SAN FRANCISCO, CA – May 20, 2020 — Cardinal Health and Vineti Inc. today announced a collaboration to...
Vineti announces new executive team members
Today, Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, is very pleased to share...
Vineti’s four-year anniversary
Happy four-year anniversary Vineti! We are proud to announce that our team has crossed another company milestone: April 10th marked our...
Advanced therapies in the COVID-19 pandemic: five guidelines for moving forward
The COVID-19 pandemic presents all of us with a dynamic, disruptive challenge unlike anything most of us have experienced in...
Quality Management Systems for advanced therapies, Part 5: what does a successful QMS look like in advanced therapies?
Note: this post is the fifth, and final post, in a five-part series on Quality Management Systems (including cGMP and...
Quality Management Systems for advanced therapies, Part 4: practical tips for de-risking the critical risks in the advanced therapy supply chain
Note: this post is the fourth in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...
Q&A: five questions for Phil Calvin
Today, Vineti is thrilled to announce that Phil Calvin has joined Vineti as our Chief Technology Officer. A veteran technology executive at...
Quality Management Systems for advanced therapies, Part 3: a risk based approach – what does this mean for advanced therapies?
Note: this post is the third in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...